A pilot feasibility trial of cognitive–behavioural therapy for insomnia in people with inflammatory bowel disease

Objective Poor sleep is common in inflammatory bowel disease (IBD), associated with worse overall disease course and predominantly attributable to insomnia. While cognitive–behavioural therapy for insomnia (CBT-I) is the recommended first-line treatment for chronic insomnia, it is untested in IBD. I...

Full description

Saved in:
Bibliographic Details
Main Authors: Kelly A Aschbrenner, Corey A Siegel, Jessica K Salwen-Deremer, Michael T Smith, Hannah G Haskell, Brittany C Speed
Format: Article
Language:English
Published: BMJ Publishing Group 2021-10-01
Series:BMJ Open Gastroenterology
Online Access:https://bmjopengastro.bmj.com/content/8/1/e000805.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846138129687248896
author Kelly A Aschbrenner
Corey A Siegel
Jessica K Salwen-Deremer
Michael T Smith
Hannah G Haskell
Brittany C Speed
author_facet Kelly A Aschbrenner
Corey A Siegel
Jessica K Salwen-Deremer
Michael T Smith
Hannah G Haskell
Brittany C Speed
author_sort Kelly A Aschbrenner
collection DOAJ
description Objective Poor sleep is common in inflammatory bowel disease (IBD), associated with worse overall disease course and predominantly attributable to insomnia. While cognitive–behavioural therapy for insomnia (CBT-I) is the recommended first-line treatment for chronic insomnia, it is untested in IBD. It is unclear if CBT-I will be as effective in this group given the extent of night-time symptoms people with IBD experience. Thus, we evaluated the feasibility and preliminary efficacy of CBT-I in IBD.Design We comprehensively assessed sleep in people with mild-to-moderately active IBD using questionnaires, daily diaries and actigraphy. People with significant insomnia symptoms were allocated to a single-arm, uncontrolled pilot feasibility study of gold-standard CBT-I treatment. They were then reassessed post-treatment.Results 20 participants with IBD completed a baseline assessment. 10 were experiencing insomnia and were allocated to CBT-I. All participants who were offered CBT-I elected to complete it, and all completed 5/5 sessions. Participants rated treatment acceptability highly and daily diary and actigraphy completion rates were >95%. At baseline, participants with insomnia evidenced significantly worse sleep than participants without insomnia. Following CBT-I, participants reported significant improvements in diary and actigraphy measures of sleep continuity, dysfunctional sleep-related beliefs and IBD disease activity.Conclusion CBT-I was feasible and acceptable and demonstrated a signal for efficacy in the treatment of insomnia in IBD. Importantly, the improvements in sleep continuity were consistent with the extant literature. Future fully powered randomised controlled studies should evaluate whether treatment of insomnia can improve other aspects of IBD, including pain and inflammation.Trial registration number NCT04132024.
format Article
id doaj-art-dbfd696ca35b49fca3410bd4da51c9c7
institution Kabale University
issn 2054-4774
language English
publishDate 2021-10-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open Gastroenterology
spelling doaj-art-dbfd696ca35b49fca3410bd4da51c9c72024-12-07T11:20:12ZengBMJ Publishing GroupBMJ Open Gastroenterology2054-47742021-10-018110.1136/bmjgast-2021-000805A pilot feasibility trial of cognitive–behavioural therapy for insomnia in people with inflammatory bowel diseaseKelly A Aschbrenner0Corey A Siegel1Jessica K Salwen-Deremer2Michael T Smith3Hannah G Haskell4Brittany C Speed5Department of Psychiatry, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USACenter for Digestive Health, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USADepartment of Psychiatry, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USADepartment of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland, USADepartment of Psychiatry, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USADepartment of Psychiatry, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USAObjective Poor sleep is common in inflammatory bowel disease (IBD), associated with worse overall disease course and predominantly attributable to insomnia. While cognitive–behavioural therapy for insomnia (CBT-I) is the recommended first-line treatment for chronic insomnia, it is untested in IBD. It is unclear if CBT-I will be as effective in this group given the extent of night-time symptoms people with IBD experience. Thus, we evaluated the feasibility and preliminary efficacy of CBT-I in IBD.Design We comprehensively assessed sleep in people with mild-to-moderately active IBD using questionnaires, daily diaries and actigraphy. People with significant insomnia symptoms were allocated to a single-arm, uncontrolled pilot feasibility study of gold-standard CBT-I treatment. They were then reassessed post-treatment.Results 20 participants with IBD completed a baseline assessment. 10 were experiencing insomnia and were allocated to CBT-I. All participants who were offered CBT-I elected to complete it, and all completed 5/5 sessions. Participants rated treatment acceptability highly and daily diary and actigraphy completion rates were >95%. At baseline, participants with insomnia evidenced significantly worse sleep than participants without insomnia. Following CBT-I, participants reported significant improvements in diary and actigraphy measures of sleep continuity, dysfunctional sleep-related beliefs and IBD disease activity.Conclusion CBT-I was feasible and acceptable and demonstrated a signal for efficacy in the treatment of insomnia in IBD. Importantly, the improvements in sleep continuity were consistent with the extant literature. Future fully powered randomised controlled studies should evaluate whether treatment of insomnia can improve other aspects of IBD, including pain and inflammation.Trial registration number NCT04132024.https://bmjopengastro.bmj.com/content/8/1/e000805.full
spellingShingle Kelly A Aschbrenner
Corey A Siegel
Jessica K Salwen-Deremer
Michael T Smith
Hannah G Haskell
Brittany C Speed
A pilot feasibility trial of cognitive–behavioural therapy for insomnia in people with inflammatory bowel disease
BMJ Open Gastroenterology
title A pilot feasibility trial of cognitive–behavioural therapy for insomnia in people with inflammatory bowel disease
title_full A pilot feasibility trial of cognitive–behavioural therapy for insomnia in people with inflammatory bowel disease
title_fullStr A pilot feasibility trial of cognitive–behavioural therapy for insomnia in people with inflammatory bowel disease
title_full_unstemmed A pilot feasibility trial of cognitive–behavioural therapy for insomnia in people with inflammatory bowel disease
title_short A pilot feasibility trial of cognitive–behavioural therapy for insomnia in people with inflammatory bowel disease
title_sort pilot feasibility trial of cognitive behavioural therapy for insomnia in people with inflammatory bowel disease
url https://bmjopengastro.bmj.com/content/8/1/e000805.full
work_keys_str_mv AT kellyaaschbrenner apilotfeasibilitytrialofcognitivebehaviouraltherapyforinsomniainpeoplewithinflammatoryboweldisease
AT coreyasiegel apilotfeasibilitytrialofcognitivebehaviouraltherapyforinsomniainpeoplewithinflammatoryboweldisease
AT jessicaksalwenderemer apilotfeasibilitytrialofcognitivebehaviouraltherapyforinsomniainpeoplewithinflammatoryboweldisease
AT michaeltsmith apilotfeasibilitytrialofcognitivebehaviouraltherapyforinsomniainpeoplewithinflammatoryboweldisease
AT hannahghaskell apilotfeasibilitytrialofcognitivebehaviouraltherapyforinsomniainpeoplewithinflammatoryboweldisease
AT brittanycspeed apilotfeasibilitytrialofcognitivebehaviouraltherapyforinsomniainpeoplewithinflammatoryboweldisease
AT kellyaaschbrenner pilotfeasibilitytrialofcognitivebehaviouraltherapyforinsomniainpeoplewithinflammatoryboweldisease
AT coreyasiegel pilotfeasibilitytrialofcognitivebehaviouraltherapyforinsomniainpeoplewithinflammatoryboweldisease
AT jessicaksalwenderemer pilotfeasibilitytrialofcognitivebehaviouraltherapyforinsomniainpeoplewithinflammatoryboweldisease
AT michaeltsmith pilotfeasibilitytrialofcognitivebehaviouraltherapyforinsomniainpeoplewithinflammatoryboweldisease
AT hannahghaskell pilotfeasibilitytrialofcognitivebehaviouraltherapyforinsomniainpeoplewithinflammatoryboweldisease
AT brittanycspeed pilotfeasibilitytrialofcognitivebehaviouraltherapyforinsomniainpeoplewithinflammatoryboweldisease